Leading the Way in Life Science Technologies

GEN Exclusives

More »

November 15, Vol. 32, No. 20

  • Columns

    • Downstream Processing Issues Leveling Off
    • Eric S. Langer
    • Since 2008, downstream purification issues have become progressively more acute problems for biomanufacturers But that’s begun to change this year, according to results from BioPlan Associates’ 9th Annual Report and Survey of Biopharmaceutical Manufacturers... more »
    • People in the News
    • Durata Therapeutics hired Allison Wey as vp of investor relations and public affairs Before joining Durata, Wey served as vp, investor relations and corporate affairs of Par Pharmaceuticals She also served as vp, investor relations and corporate communications at Boron, ... more »